Multiple peripheral arteries stent
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
10-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Medtronic Australasia Pty Ltd
Class:
Class IIb
Manufactured by:
ev3 Inc 4600 Nathan Lane North, Plymouth, Minnesota, 55442 United States Of America
Therapeutic area:
47932 - Multiple peripheral arteries stent
Therapeutic indications:
The stent is indicated for use in occlusions, lesions at high risk for abrupt closure or threatened closure following percutaneous transluminal angioplasty (PTA); or lesions believed to be at high risk for restenosis following PTA in the external iliac, superficial femoral, proximal popliteal or subclavian arteries. Stenting is intended to improve and maintain artery luminal diameter.
Authorization status:
A
Authorization date:
2013-10-14
